Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)

¹Any op­er­a­tions re­lat­ing to blood and labile blood products, in par­tic­u­lar the ex­trac­tion, man­u­fac­ture, pro­cessing, stor­age and the pla­cing on the mar­ket, must be con­duc­ted in ac­cord­ance with the prin­ciples of qual­ity man­age­ment and the re­cog­nised prin­ciples of good man­u­fac­tur­ing prac­tice in the hand­ling of blood and blood products.

² Blood and labile blood products as well as as­so­ci­ated blood samples must be la­belled such that they can be un­am­bigu­ously iden­ti­fied at any time.

³ The Fed­er­al Coun­cil shall spe­cify the re­cog­nised rules of good man­u­fac­tur­ing prac­tice. In do­ing so, it shall take ac­count of in­ter­na­tion­ally re­cog­nised guidelines and stand­ards.